199 related articles for article (PubMed ID: 35483200)
1. Hepatocellular carcinoma organoid co-cultures mimic angiocrine crosstalk to generate inflammatory tumor microenvironment.
Lim JTC; Kwang LG; Ho NCW; Toh CCM; Too NSH; Hooi L; Benoukraf T; Chow PK; Dan YY; Chow EK; Toh TB; Fong ELS
Biomaterials; 2022 May; 284():121527. PubMed ID: 35483200
[TBL] [Abstract][Full Text] [Related]
2. Microenvironment of a tumor-organoid system enhances hepatocellular carcinoma malignancy-related hallmarks.
Wang Y; Takeishi K; Li Z; Cervantes-Alvarez E; Collin de l'Hortet A; Guzman-Lepe J; Cui X; Zhu J
Organogenesis; 2017 Jul; 13(3):83-94. PubMed ID: 28548903
[TBL] [Abstract][Full Text] [Related]
3. EphA1 activation promotes the homing of endothelial progenitor cells to hepatocellular carcinoma for tumor neovascularization through the SDF-1/CXCR4 signaling pathway.
Wang Y; Yu H; Shan Y; Tao C; Wu F; Yu Z; Guo P; Huang J; Li J; Zhu Q; Yu F; Song Q; Shi H; Zhou M; Chen G
J Exp Clin Cancer Res; 2016 Apr; 35():65. PubMed ID: 27066828
[TBL] [Abstract][Full Text] [Related]
4. Plasma-derived extracellular matrix for xenofree and cost-effective organoid modeling for hepatocellular carcinoma.
El-Derby AM; Khedr MA; Ghoneim NI; Gabr MM; Khater SM; El-Badri N
J Transl Med; 2024 May; 22(1):487. PubMed ID: 38773585
[TBL] [Abstract][Full Text] [Related]
5. Supramolecular Polymer-Nanomedicine Hydrogel Loaded with Tumor Associated Macrophage-Reprogramming polyTLR7/8a Nanoregulator for Enhanced Anti-Angiogenesis Therapy of Orthotopic Hepatocellular Carcinoma.
Liu X; Huangfu Y; Wang J; Kong P; Tian W; Liu P; Fang C; Li S; Nie Y; Feng Z; Huang P; Shi S; Zhang C; Dong A; Wang W
Adv Sci (Weinh); 2023 Aug; 10(22):e2300637. PubMed ID: 37229748
[TBL] [Abstract][Full Text] [Related]
6. Angiogenesis in hepatocellular carcinoma: mechanisms and anti-angiogenic therapies.
Yao C; Wu S; Kong J; Sun Y; Bai Y; Zhu R; Li Z; Sun W; Zheng L
Cancer Biol Med; 2023 Jan; 20(1):25-43. PubMed ID: 36647777
[TBL] [Abstract][Full Text] [Related]
7. Crosstalk between hepatic tumor cells and macrophages via Wnt/β-catenin signaling promotes M2-like macrophage polarization and reinforces tumor malignant behaviors.
Yang Y; Ye YC; Chen Y; Zhao JL; Gao CC; Han H; Liu WC; Qin HY
Cell Death Dis; 2018 Jul; 9(8):793. PubMed ID: 30022048
[TBL] [Abstract][Full Text] [Related]
8. Cancer-Associated Fibroblasts Provide a Stromal Niche for Liver Cancer Organoids That Confers Trophic Effects and Therapy Resistance.
Liu J; Li P; Wang L; Li M; Ge Z; Noordam L; Lieshout R; Verstegen MMA; Ma B; Su J; Yang Q; Zhang R; Zhou G; Carrascosa LC; Sprengers D; IJzermans JNM; Smits R; Kwekkeboom J; van der Laan LJW; Peppelenbosch MP; Pan Q; Cao W
Cell Mol Gastroenterol Hepatol; 2021; 11(2):407-431. PubMed ID: 32932015
[TBL] [Abstract][Full Text] [Related]
9. Tumor-endothelial cell interaction in an experimental model of human hepatocellular carcinoma.
Jamshidi-Parsian A; Griffin RJ; Kore RA; Todorova VK; Makhoul I
Exp Cell Res; 2018 Nov; 372(1):16-24. PubMed ID: 30205087
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial cells facilitated HCC invasion and metastasis through the Akt and NF-κB pathways induced by paracrine cytokines.
Wang YH; Dong YY; Wang WM; Xie XY; Wang ZM; Chen RX; Chen J; Gao DM; Cui JF; Ren ZG
J Exp Clin Cancer Res; 2013 Aug; 32(1):51. PubMed ID: 23941552
[TBL] [Abstract][Full Text] [Related]
11. Apatinib targets both tumor and endothelial cells in hepatocellular carcinoma.
Yang C; Qin S
Cancer Med; 2018 Sep; 7(9):4570-4583. PubMed ID: 30109780
[TBL] [Abstract][Full Text] [Related]
12. Modelling liver cancer microenvironment using a novel 3D culture system.
Al Hrout A; Cervantes-Gracia K; Chahwan R; Amin A
Sci Rep; 2022 May; 12(1):8003. PubMed ID: 35568708
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo.
Garcia MG; Bayo J; Bolontrade MF; Sganga L; Malvicini M; Alaniz L; Aquino JB; Fiore E; Rizzo MM; Rodriguez A; Lorenti A; Andriani O; Podhajcer O; Mazzolini G
Mol Pharm; 2011 Oct; 8(5):1538-48. PubMed ID: 21770423
[TBL] [Abstract][Full Text] [Related]
14. Higher proliferation of peritumoral endothelial cells to IL-6/sIL-6R than tumoral endothelial cells in hepatocellular carcinoma.
Zhuang PY; Wang JD; Tang ZH; Zhou XP; Quan ZW; Liu YB; Shen J
BMC Cancer; 2015 Nov; 15():830. PubMed ID: 26525581
[TBL] [Abstract][Full Text] [Related]
15. The inflammatory microenvironment in hepatocellular carcinoma: a pivotal role for tumor-associated macrophages.
Capece D; Fischietti M; Verzella D; Gaggiano A; Cicciarelli G; Tessitore A; Zazzeroni F; Alesse E
Biomed Res Int; 2013; 2013():187204. PubMed ID: 23533994
[TBL] [Abstract][Full Text] [Related]
16. Context dependent role of p53 during the interaction of hepatocellular carcinoma and endothelial cells.
Ghufran SM; Sharma S; Ghose S; Biswas S
Microvasc Res; 2022 Jul; 142():104374. PubMed ID: 35523268
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-induced myeloid derived growth factor promotes hepatocellular carcinoma progression through remodeling tumor microenvironment.
Wang X; Mao J; Zhou T; Chen X; Tu H; Ma J; Li Y; Ding Y; Yang Y; Wu H; Tang X
Theranostics; 2021; 11(1):209-221. PubMed ID: 33391471
[No Abstract] [Full Text] [Related]
18. Intestinal dysbacteriosis-induced IL-25 promotes development of HCC via alternative activation of macrophages in tumor microenvironment.
Li Q; Ma L; Shen S; Guo Y; Cao Q; Cai X; Feng J; Yan Y; Hu T; Luo S; Zhou L; Peng B; Yang Z; Hua Y
J Exp Clin Cancer Res; 2019 Jul; 38(1):303. PubMed ID: 31296243
[TBL] [Abstract][Full Text] [Related]
19. Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma.
Li X; Yao W; Yuan Y; Chen P; Li B; Li J; Chu R; Song H; Xie D; Jiang X; Wang H
Gut; 2017 Jan; 66(1):157-167. PubMed ID: 26452628
[TBL] [Abstract][Full Text] [Related]
20. Hedgehog signaling promotes sorafenib resistance in hepatocellular carcinoma patient-derived organoids.
Wang S; Wang Y; Xun X; Zhang C; Xiang X; Cheng Q; Hu S; Li Z; Zhu J
J Exp Clin Cancer Res; 2020 Jan; 39(1):22. PubMed ID: 31992334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
